St. Alphonsus Health System
Print    Email
Decrease (-) Restore Default Increase (+)

Health Information

 

Minimal change disease

Definition

Minimal change disease is a kidney disorder that can lead to nephrotic syndrome, although the nephrons of the kidney look normal under a regular microscope.

Alternative Names

Minimal change nephrotic syndrome; Nil disease; Lipoid nephrosis; Idiopathic nephrotic syndrome of childhood

Causes, incidence, and risk factors

Each kidney is made of more than a million units called nephrons, which filter blood and produce urine.

In minimal change disease, there is damage to the glomeruli -- the tiny blood vessels inside the nephron where blood is filtered to make urine and waste is removed. The disease gets its name because this damage is not visible under a regular microscope. It can only be seen under an electron microscope.

Minimal change disease is the most common cause of nephrotic syndrome in children. It causes about 80% of cases in young children. It is also seen in adults, but makes up only 10 to 15% of nephrotic syndrome cases.

The cause is unknown, but the disease may occur after or be related to:

  • Allergic reactions
  • NSAID use
  • Tumors
  • Vaccinations
  • Viral infections

Symptoms

There may be symptoms of nephrotic syndrome:

  • Foamy appearance of the urine
  • Poor appetite
  • Swelling (especially around the eyes, feet, and ankles, and in the abdomen)
  • Weight gain (from fluid retention)

Minimal change disease does not reduce the amount of urine produced. It rarely progresses to kidney failure.

Signs and tests

The doctor may not be able to see any signs of the disease, other than swelling. Blood and urine tests reveal signs of nephrotic syndrome, including:

  • High cholesterol
  • High levels of protein in the urine
  • Low levels of albumin in the blood

A kidney biopsy and examination of the tissue with an electron microscope can show signs of minimal change disease. An immunofluorescence exam of the biopsied kidney tissue will be negative.

Treatment

Corticosteroids can cure minimal change disease in most children. Some patients may need to stay on steroids to keep the disease in remission.

Adults do not respond to steroids as well as children, but many still find steroids effective. Adults may have more frequent relapses and become dependent on steroids.

Patients who have three or more relapses may do better with cytotoxic therapy instead of steroids. In most cases, this involves a medication called cyclophosphamide. Other medicines that have been used include cyclosporine and chlorambucil.

Swelling may be treated with:

  • ACE inhibitor medicines
  • Blood pressure control
  • Diuretics (water pills)

You may also be told to reduce the amount of salt in your diet.

Expectations (prognosis)

Children with minimal change disease usually respond better to corticosteroids than adults. Children often respond within the first month.

A relapse can occur. However, patients may improve after long-term treatment with corticosteroids and medications that suppress the immune system (immunosuppressive medications).

Complications

Calling your health care provider

Call for an appointment with your health care provider if:

  • You develop symptoms of minimal change disease
  • You have this disorder and your symptoms get worse
  • You develop new symptoms, including side effects from the medications used to treat the disorder

Prevention

There is no known prevention.

References

Appel GB. Glomerular disorders and nephrotic syndromes. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 122.

Nachman PH, Jennette JC, Falk RJ. Primary glomerular disease. In: Brenner BM, ed. Brenner and Rector's The Kidney. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 30.

Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, St. Geme JW III, Schor NF, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 521.


Review Date: 9/20/2011
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Herbert Y. Lin, MD, PHD, Nephrologist, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 

©

 2014  

Saint Alphonsus Health System  |  1055 North Curtis Road  Boise, ID 83706  |  208-367-2121

   Facebook       Twitter       YouTube